Aaron B Waxman
Brigham and Women's Hospital, Pulmonary Vascular Disease Program · Brigham and Women's Hospital
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Aaron B Waxman as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 07:23 UTC. Open this list on ClinicalTrials.gov
- Ph4NCT07112183 · Open Label Treprostinil Raynaud's StudyBrigham and Women's Hospital · recruiting · Raynaud's Disease, Raynaud Phenomena, Raynauds · principal investigator
- Ph4NCT04231084 · Comparison of Vasodilator Response of Inhaled Epoprostenol and Inhaled Nitric OxideBrigham and Women's Hospital · completed · Pulmonary Hypertension · principal investigator
- Ph1/Ph2NCT03166306 · Angiogenic Imaging in Pulmonary Arterial HypertensionBrigham and Women's Hospital · completed · Pulmonary Arterial Hypertension, Exercise Associated Pulmonary Arterial Hypertension · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 07:23 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 2 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
- Intergrated Endothelial Phenotyping to Redefine Pulmonary HypertensionU01HL125215 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · fiscal years 2014 to 2018 · $355,000 awarded in 2018Same name and institution; not confirmed by an ID
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 07:23 UTC. The ranking covers the 200 most relevant of 17 PubMed records, and a shared surname and initials can bring in a namesake. All 17 on PubMed
- 638 citationsRCR 78.8
- PVDOMICS: A Multi-Center Study to Improve Understanding of Pulmonary Vascular Disease Through Phenomics.Circ Res · 2017152 citationsRCR 5.5
- Sotatercept in Patients with Pulmonary Arterial Hypertension at High Risk for Death.N Engl J Med · 2025139 citationsRCR 46.4
- Sotatercept for the treatment of pulmonary arterial hypertension: PULSAR open-label extension.Eur Respir J · 2023137 citationsRCR 16.6
- Effectiveness of spironolactone plus ambrisentan for treatment of pulmonary arterial hypertension (from the [ARIES] study 1 and 2 trials).Am J Cardiol · 201377 citationsRCR 2.5
- SPECTRA Phase 2b Study: Impact of Sotatercept on Exercise Tolerance and Right Ventricular Function in Pulmonary Arterial Hypertension.Circ Heart Fail · 202461 citationsRCR 10.8
- Sotatercept for Pulmonary Arterial Hypertension within the First Year after Diagnosis.N Engl J Med · 202561 citationsRCR 20.1
- 46 citationsRCR 1.9
- 40 citationsRCR 4.8
- Conversion to bosentan from prostacyclin infusion therapy in pulmonary arterial hypertension: a pilot study.Chest · 200636 citationsRCR 1.0